Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Bertolini, Marta ^a,b   Zilio, Federica ^a   Rossi, Alfredo ^c   Kleditzsch, Patrick ^d   Emelianov, Vladimir E ^e   Gilhar, Amos ^f,g   Keren, Aviad ^f   Meyer, Katja C ^a   Wang, Eddy ^h   Funk, Wolfgang ⁱ   McElwee, Kevin ^h   Paus, Ralf ^a,b,j  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e CHUVASH STATE UNIVERSITY   (Russian Federation)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g Flieman Geriatric Rehabilitation Hospital   (Israel)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ Klinik Dr Koslowski   (Germany)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; CD30 LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OX40 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; TRANSFORMING GROWTH FACTOR BETA1; TRYPTASE;

ADULT; ALOPECIA AREATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VIVO STUDY; MAST CELL; MAST CELL DEGRANULATION; MORPHOMETRICS; MOUSE; NONHUMAN; PATHOGENESIS; PERIFOLLICULAR MAST CELL; PHENOTYPIC PLASTICITY; QUANTITATIVE ANALYSIS; SKIN GRAFT; ANIMAL; BIOPSY; BLOOD; C3H MOUSE; CYTOLOGY; HAIR FOLLICLE; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; SKIN;

ALOPECIA AREATA; ANIMALS; BIOPSY; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; FEMALE; HAIR FOLLICLE; HUMANS; INFLAMMATION; INTERLEUKIN-10; MAST CELLS; MICE; MICE, INBRED C3H; MIDDLE AGED; PHENOTYPE; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84901322178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094260     Document Type: Article

References (130)

1. Gilhar A, Etzioni A, Paus R (2012) Alopecia areata. N Engl J Med 366: 1515-1525.
2. McElwee KJ, Gilhar A, Tobin DJ, Ramot Y, Sundberg JP, et al. (2013) What causes alopecia areata?: Exp Dermatol 22: 609-626.
3. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, et al. (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/ CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 124:947-57. (Pubitemid 40629095)
4. McElwee KJ, Spiers EM, Oliver RF (1996) In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol 135: 211-217. (Pubitemid 26252968)
5. Gilhar A, Keren A, Shemer A, d'Ovidio R, Ullmann Y, et al. (2013) Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata. J Invest Dermatol 133: 844-847.
6. Kang H, Wu WY, Lo BK, Yu M, Leung G, et al. (2010) Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 130: 2677-2680.
7. Kinori M, Kloepper JE, Paus R (2011) Can the hair follicle become a model for studying selected aspects of human ocular immune privilege? Invest Ophthalmol Vis Sci 52: 4447-4458.
8. Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, et al. (2008) Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 159: 1077-1085.
9. Paus R, Nickoloff BJ, Ito T (2005) A 'hairy' privilege. Trends Immunol 26: 32-40. (Pubitemid 40051990)
10. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, Sundberg JP, Vitacolonna M, et al. (2006) Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 155: 515-521. (Pubitemid 44215480)
11. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, et al. (2004) Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 164: 623-634. (Pubitemid 38364677)
12. Baccaredda-Boy A, Giacometti A (1959) Clinical observations and experimental research on thyrotropin in pretibial limited myxodermia. Panminerva Med 1: 198-201.
13. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, et al. (2000) Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 114: 112-116. (Pubitemid 30195982)
14. Cetin ED, Savk E, Uslu M, Eskin M, Karul A (2009) Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 31: 53-60.
15. D'Ovidio R, Vena GA, Angelini G (1988) [Possible immunopathogenetic role of mastocytes in alopecia areata]. G Ital Dermatol Venereol 123: 569-570.
16. Finzi AF, Landi G (1964) [Action of the mast cell depletor 48/80 on skin temperature in alopecia areata]. Minerva Dermatol 39: 99-102.
17. Ito T, Ito N, Saatoff M, Hashizume H, Fukamizu H, et al. (2008) Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128: 1196-1206. (Pubitemid 351543218)
18. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E (1984) Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 83: 7-11. (Pubitemid 14080891)
19. Alli R, Nguyen P, Boyd K, Sundberg JP, Geiger TL (2012) A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. J Immunol 188: 477-486.
20. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish RS (1998) Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 101: 62-67. (Pubitemid 28058903)
21. Ito T, Bertolini M, Funakoshi A, Ito N, Takayama T, et al. (2013) Birth, life, and death of the MAGE3 hypothesis of alopecia areata pathobiology. J Dermatol Sci 72: 327-30.
22. Paus R, Slominski A, Czarnetzki BM (1993) Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 66: 541-554.
23. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, et al. (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466: 113-117.
24. Yano S, Nakamura K, Okochi H, Tamaki K (2002) Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients. Acta Derm Venereol 82: 82-85. (Pubitemid 34596677)
25. Brown MA, Hatfield JK (2012) Mast cells are important modifiers of autoimmune disease: With so much evidence, why is there still controversy? Front Immunol 3: 147.
26. Frenzel L, Hermine O (2013) Mast cells and inflammation. Joint Bone Spine 80: 141-145.
27. Frossi B, Gri G, Tripodo C, Pucillo C (2010) Exploring a regulatory role for mast cells: 'MCregs'? Trends Immunol 31: 97-102.
28. Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478-486. (Pubitemid 351733419)
29. Gri G, Frossi B, D'Inca F, Danelli L, Betto E, et al. (2012) Mast cell: an emerging partner in immune interaction. Front Immunol 3: 120.
30. Harvima IT, Nilsson G (2011) Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol 91: 644-650.
31. Sayed BA, Christy A, Quirion MR, Brown MA (2008) The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 26: 705-739. (Pubitemid 351600390)
32. St John AL, Abraham SN (2013) Innate immunity and its regulation by mast cells. J Immunol 190: 4458-4463.
33. Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, et al. (2012) Role of mast cells in innate and adaptive immunity. J Biol Regul Homeost Agents 26: 193-201.
34. Tsai M, Grimbaldeston M, Galli SJ (2011) Mast cells and immunoregulation/immunomodulation. Adv Exp Med Biol 716: 186-211.
35. Stelekati E, Bahri R, D'Orlando O, Orinska Z, Mittrucker HW, et al. (2009) Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 31: 665-676.
36. Christy AL, Walker ME, Hessner MJ, Brown MA (2013) Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun 42: 50-61.
37. Gan PY, Summers SA, Ooi JD, O'Sullivan KM, Tan DS, et al. (2012) Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis. J Am Soc Nephrol 23: 1955-1966.
38. Gilfillan AM, Beaven MA (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31: 475-529.
39. Walker ME, Hatfield JK, Brown MA (2012) New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta 1822: 57-65.
40. Botchkarev VA, Paus R, Czarnetzki BM, Kupriyanov VS, Gordon DS, et al. (1995) Hair cycle-dependent changes in mast cell histochemistry in murine skin. Arch Dermatol Res 287: 683-686.
41. Maurer M, Paus R, Czarnetzki BM (1995) Mast cells as modulators of hair follicle cycling. Exp Dermatol 4: 266-271.
42. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, et al. (2003) What is the physiological function of mast cells? Exp Dermatol 12: 886-910.
43. Paus R, Maurer M, Slominski A, Czarnetzki BM (1994) Mast cell involvement in murine hair growth. Dev Biol 163: 230-240. (Pubitemid 24188887)
44. Maurer M, Fischer E, Handjiski B, von Stebut E, Algermissen B, et al. (1997) Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest 77: 319-332. (Pubitemid 27465594)
45. Ito N, Sugawara K, Bodo E, Takigawa M, van Beek N, et al. (2010) Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 130: 995-1004.
46. Kumamoto T, Shalhevet D, Matsue H, Mummert ME, Ward BR, et al. (2003) Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 102: 1654-1660. (Pubitemid 37022557)
47. Sugawara K, Biro T, Tsuruta D, Toth BI, Kromminga A, et al. (2012) Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 129: 726-738 e728.
48. Voehringer D (2013) Protective and pathological roles of mast cells and basophils. Nat Rev Immunol 13: 362-375.
49. Chan CY, St John AL, Abraham SN (2013) Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity 38: 349-359.
50. de Vries VC, Pino-Lagos K, Elgueta R, Noelle RJ (2009) The enigmatic role of mast cells in dominant tolerance. Curr Opin Organ Transplant 14: 332-337.
51. Kalesnikoff J, Galli SJ (2011) Antiinflammatory and immunosuppressive functions of mast cells. Methods Mol Biol 677: 207-220.
52. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, et al. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002. (Pubitemid 44330250)
53. Waldmann H (2006) Immunology: protection and privilege. Nature 442: 987-988.
54. de Vries VC, Wasiuk A, Bennett KA, Benson MJ, Elgueta R, et al. (2009) Mast cell degranulation breaks peripheral tolerance. Am J Transplant 9: 2270-2280.
55. King LE Jr., McElwee KJ, Sundberg JP (2008) Alopecia areata. Curr Dir Autoimmun 10: 280-312.
56. Wang E, Chong K, Yu M, Akhoundsadegh N, Granville DJ, et al. (2013) Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One 8: e62935.
57. Gilhar A, Keren A, Shemer A, Ullmann Y, Paus R (2013) Blocking potassium channels (Kv1.3): a new treatment option for alopecia areata? J Invest Dermatol 133: 2088-2091.
58. Bertolini M, Meyer KC, Slominski R, Kobayashi K, Ludwig RJ, et al. (2013) The immune system of mouse vibrissae follicles: cellular composition and indications of immune privilege. Exp Dermatol 22: 593-598.
59. Harries MJ, Meyer K, Chaudhry I, J EK, Poblet E, et al. (2013) Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche. J Pathol 231: 236-247.
60. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, et al. (2005) Human hair follicles display a functional equivalent of the hypothalamic-pituitary- adrenal axis and synthesize cortisol. FASEB J 19: 1332-1334. (Pubitemid 41113740)
61. Kloepper JE, Kawai K, Bertolini M, Kanekura T, Paus R (2013) Loss of gamma/delta T cells results in hair cycling defects. J Invest Dermatol 133: 1666-1669.
62. Spath U, Steigleder GK (1970) [Number of mast cells (MC) in Alopecia areata]. Z Haut Geschlechtskr 45: 435-436.
63. Algermissen B, Bauer F, Schadendorf D, Kropp JD, Czarnetzki BM (1994) Analysis of mast cell subpopulations (MCT, MCTC) in cutaneous inflammation using novel enzyme-histochemical staining techniques. Exp Dermatol 3: 290-297.
64. Buckley MG, McEuen AR, Walls AF (1999) The detection of mast cell subpopulations in formalin-fixed human tissues using a new monoclonal antibody specific for chymase. J Pathol 189: 138-143. (Pubitemid 29406831)
65. Whiting DA (2003) Histopathologic features of alopecia areata: a new look. Arch Dermatol 139: 1555-1559.
66. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, et al. (2010) Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 126: 1198-1204 e1194.
67. Gordon JR, Galli SJ (1994) Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha. J Exp Med 180: 2027-2037.
68. Hugle T, Hogan V, White KE, van Laar JM (2011) Mast cells are a source of transforming growth factor beta in systemic sclerosis. Arthritis Rheum 63: 795-799.
69. Wahl SM, Wen J, Moutsopoulos N (2006) TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 213: 213-227. (Pubitemid 44401503)
70. Hernandez-Hernandez L, Sanz C, Garcia-Solaesa V, Padron J, Garcia-Sanchez A, et al. (2012) Tryptase: genetic and functional considerations. Allergol Immunopathol (Madr) 40: 385-389.
71. Li Q, Jie Y, Wang C, Zhang Y, Guo H, et al. (2014) Tryptase compromises corneal epithelial barrier function. Cell Biochem Funct 32: 183-7.
72. Magarinos NJ, Bryant KJ, Fosang AJ, Adachi R, Stevens RL, et al. (2013) Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens. J Immunol 191: 1404-1412.
73. Pejler G, Ronnberg E, Waern I, Wernersson S (2010) Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 115: 4981-4990.
74. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, et al. (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 182: 647-656.
75. Zeng X, Zhang S, Xu L, Yang H, He S (2013) Activation of protease-activated receptor 2-mediated signaling by mast cell tryptase modulates cytokine production in primary cultured astrocytes. Mediators Inflamm 2013: 140812.
76. Kashiwakura J, Yokoi H, Saito H, Okayama Y (2004) T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173: 5247-5257. (Pubitemid 39387808)
77. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, et al. (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176: 2238-2248. (Pubitemid 43201671)
78. Nagai H, Oniki S, Oka M, Horikawa T, Nishigori C (2006) Induction of cellular immunity against hair follicle melanocyte causes alopecia. Arch Dermatol Res 298: 131-134. (Pubitemid 44341646)
79. Tsuboi H, Tanei R, Fujimura T, Ohta Y, Katsuoka K (1999) Characterization of infiltrating T cells in human scalp explants from alopecia areata to SCID nude mice: possible role of the disappearance of CD8+ T lymphocytes in the process of hair regrowth. J Dermatol 26: 797-802. (Pubitemid 30073682)
80. Croft M (2010) Control of immunity by the TNFR-related molecule OX40 (CD134). Annu Rev Immunol 28: 57-78.
81. Ilves T, Harvima IT (2013) OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity. J Eur Acad Dermatol Venereol 27: e197-205.
82. Ishii N, Takahashi T, Soroosh P, Sugamura K (2010) OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol 105: 63-98.
83. Kober J, Leitner J, Klauser C, Woitek R, Majdic O, et al. (2008) The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur J Immunol 38: 2678-2688.
84. Weinberg AD, Morris NP, Kovacsovics-Bankowski M, Urba WJ, Curti BD (2011) Science gone translational: the OX40 agonist story. Immunol Rev 244: 218-231.
85. Zhang Z, Sferra TJ, Eroglu Y (2013) T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis? Dig Dis Sci 58: 1497-1506.
86. Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, et al. (2007) Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma. Cancer Immunol Immunother 56: 1407-1415. (Pubitemid 47024710)
87. Fischer M, Harvima IT, Carvalho RF, Moller C, Naukkarinen A, et al. (2006) Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 116: 2748-2756. (Pubitemid 44511638)
88. Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, et al. (2001) Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 114: 616-623. (Pubitemid 32953640)
89. Cabrera CM, Urra JM, Carreno A, Zamorano J (2013) Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus. Scand J Immunol 78: 306-312.
90. Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, et al. (1996) CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues. Am J Pathol 149: 469-481. (Pubitemid 26256335)
91. Horie R, Watanabe T (1998) CD30: expression and function in health and disease. Semin Immunol 10: 457-470. (Pubitemid 28564375)
92. Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, et al. (2002) Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC Immunol 3: 5.
93. Chacon JA, Wu RC, Sukhumalchandra P, Molldrem JJ, Sarnaik A, et al. (2013) Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive Tcell therapy. PLoS One 8: e60031.
94. Shao Z, Schwarz H (2011) CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J Leukoc Biol 89: 21-29.
95. Vinay DS, Kwon BS (2012) Immunotherapy of cancer with 4-1BB. Mol Cancer Ther 11: 1062-1070.
96. Wang C, Lin GH, McPherson AJ, Watts TH (2009) Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 229: 192-215.
97. Watts TH (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
98. Wu C, Guo H, Wang Y, Gao Y, Zhu Z, et al. (2011) Extracellular domain of human 4-1BBL enhanced the function of cytotoxic T-lymphocyte induced by dendritic cell. Cell Immunol 271: 118-123.
99. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142. (Pubitemid 40268194)
100. Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, et al. (2001) Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166: 868-876. (Pubitemid 32060240)
101. Chacon-Salinas R, Limon-Flores AY, Chavez-Blanco AD, Gonzalez-Estrada A, Ullrich SE (2011) Mast cell-derived IL-10 suppresses germinal center formation by affecting T follicular helper cell function. J Immunol 186: 25-31.
102. Groux H, Bigler M, de Vries JE, Roncarolo MG (1998) Inhibitory and stimulatory effects of IL-10 on human CD8 + T cells. J Immunol 160: 3188-3193. (Pubitemid 28164707)
103. Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218.
104. Soyer OU, Akdis M, Ring J, Behrendt H, Crameri R, et al. (2013) Mechanisms of peripheral tolerance to allergens. Allergy 68: 161-170.
105. Wang X, Marr AK, Breitkopf T, Leung G, Hao J, et al. (2014) Hair follicle mesenchyme-associated PD-L1 regulates T-Cell activation induced apoptosis: A potential mechanism of immune privilege. J Invest Dermatol. 134: 736-45.
106. Keir ME, Butte MJ, Freeman GJ, Sharpe AH (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704. (Pubitemid 351600389)
107. Podojil JR, Miller SD (2013) Targeting the B7 family of co-stimulatory molecules: successes and challenges. BioDrugs 27: 1-13.
108. Saresella M, Rainone V, Al-Daghri NM, Clerici M, Trabattoni D (2012) The PD-1/PD-L1 pathway in human pathology. Curr Mol Med 12: 259-267.
109. Wu YL, Liang J, Zhang W, Tanaka Y, Sugiyama H (2012) Immunotherapies: the blockade of inhibitory signals. Int J Biol Sci 8: 1420-1430.
110. Rosenblum MD, Yancey KB, Olasz EB, Truitt RL (2006) CD200, a "no danger" signal for hair follicles. J Dermatol Sci 41: 165-174. (Pubitemid 43246717)
111. Rygiel TP, Meyaard L (2012) CD200R signaling in tumor tolerance and inflammation: A tricky balance. Curr Opin Immunol 24: 233-238.
112. Cherwinski HM, Murphy CA, Joyce BL, Bigler ME, Song YS, et al. (2005) The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J Immunol 174: 1348-1356.
113. Inui S, Nakajima T, Itami S (2007) Two cases of alopecia areata responsive to fexofenadine. J Dermatol 34: 852-854. (Pubitemid 350233355)
114. Ito T, Fujiyama T, Hashizume H, Tokura Y (2013) Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata. J Dermatol Sci 72: 68-71.
115. Ohyama M, Shimizu A, Tanaka K, Amagai M (2010) Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata. J Dermatol Sci 58: 154-157.
116. Ito T, Ito N, Saathoff M, Bettermann A, Takigawa M, et al. (2005) Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol 152: 623-631. (Pubitemid 40571291)
117. Ruckert R, Hofmann U, van der Veen C, Bulfone-Paus S, Paus R (1998) MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 111: 25-30. (Pubitemid 28309204)
118. Reber LL, Marichal T, Galli SJ (2012) New models for analyzing mast cell functions in vivo. Trends Immunol 33: 613-625.
119. Finn DF, Walsh JJ (2013) Twenty-first century mast cell stabilizers. Br J Pharmacol 170: 23-37.
120. Karra L, Berent-Maoz B, Ben-Zimra M, Levi-Schaffer F (2009) Are we ready to downregulate mast cells? Curr Opin Immunol 21: 708-714.
121. Theoharides TC, Kempuraj D, Iliopoulou BP (2007) Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. Adv Exp Med Biol 601: 423-430.
122. Vieira Dos Santos R, Magerl M, Martus P, Zuberbier T, Church MK, et al. (2010) Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus. Br J Dermatol 162: 674-676.
123. Harries MJ, Sun J, Paus R, King LE Jr. (2010) Management of alopecia areata. BMJ 341: c3671.
124. Gupta MA, Gupta AK, Watteel GN (1997) Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 77: 296-298. (Pubitemid 27286464)
125. Matzer F, Egger JW, Kopera D (2011) Psychosocial stress and coping in alopecia areata: a questionnaire survey and qualitative study among 45 patients. Acta Derm Venereol 91: 318-327.
126. Paus R, Arck P (2009) Neuroendocrine perspectives in alopecia areata: does stress play a role? J Invest Dermatol 129: 1324-1326.
127. Catley MC, Coote J, Bari M, Tomlinson KL (2011) Monoclonal antibodies for the treatment of asthma. Pharmacol Ther 132: 333-351.
128. Gizinski AM, Fox DA, Sarkar S (2010) Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets. Best Pract Res Clin Rheumatol 24: 463-477.
129. Crilly A, Burns E, Nickdel MB, Lockhart JC, Perry ME, et al. (2012) PAR(2) expression in peripheral blood monocytes of patients with rheumatoid arthritis. Ann Rheum Dis 71: 1049-1054.
130. Michael ES, Kuliopulos A, Covic L, Steer ML, Perides G (2013) Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis. Am J Physiol Gastrointest Liver Physiol 304: G516-526.